 Brian Niemeyer
Concepts (79)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Virus Activation | 3 | 2021 | 94 | 1.280 |
Why?
| | Gene Expression Regulation, Viral | 2 | 2021 | 93 | 1.190 |
Why?
| | Gammaherpesvirinae | 3 | 2021 | 45 | 0.810 |
Why?
| | Cyclins | 2 | 2021 | 79 | 0.790 |
Why?
| | Virus Latency | 3 | 2021 | 90 | 0.790 |
Why?
| | Herpesviridae Infections | 2 | 2021 | 148 | 0.660 |
Why?
| | Antigens, Viral | 1 | 2021 | 182 | 0.660 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p18 | 2 | 2018 | 15 | 0.660 |
Why?
| | Viral Proteins | 1 | 2021 | 350 | 0.580 |
Why?
| | Virus Replication | 1 | 2021 | 521 | 0.560 |
Why?
| | Drug Discovery | 1 | 2018 | 153 | 0.500 |
Why?
| | Nuclear Proteins | 1 | 2021 | 740 | 0.480 |
Why?
| | Sarcoma, Ewing | 2 | 2015 | 103 | 0.470 |
Why?
| | PTEN Phosphohydrolase | 1 | 2015 | 165 | 0.400 |
Why?
| | Tissue Engineering | 1 | 2018 | 439 | 0.390 |
Why?
| | Pneumonia, Viral | 1 | 2018 | 389 | 0.370 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2015 | 382 | 0.370 |
Why?
| | Gene Expression Regulation, Neoplastic | 2 | 2015 | 1443 | 0.340 |
Why?
| | Lung | 1 | 2018 | 4106 | 0.210 |
Why?
| | Proto-Oncogene Protein c-fli-1 | 2 | 2015 | 30 | 0.190 |
Why?
| | Respiratory Mucosa | 1 | 2022 | 322 | 0.150 |
Why?
| | Down Syndrome | 1 | 2026 | 525 | 0.140 |
Why?
| | Tissue Culture Techniques | 1 | 2018 | 82 | 0.130 |
Why?
| | Lab-On-A-Chip Devices | 1 | 2018 | 61 | 0.130 |
Why?
| | Drug Evaluation, Preclinical | 1 | 2018 | 196 | 0.130 |
Why?
| | Liver | 1 | 2026 | 1896 | 0.130 |
Why?
| | Gene Knockdown Techniques | 1 | 2018 | 333 | 0.130 |
Why?
| | Epithelial Cells | 1 | 2022 | 1131 | 0.120 |
Why?
| | Anticoagulants | 1 | 2021 | 748 | 0.120 |
Why?
| | Mice | 4 | 2026 | 18329 | 0.120 |
Why?
| | Animals | 6 | 2026 | 38030 | 0.120 |
Why?
| | Antiviral Agents | 1 | 2021 | 769 | 0.110 |
Why?
| | MicroRNAs | 2 | 2012 | 686 | 0.110 |
Why?
| | Cell Culture Techniques | 1 | 2018 | 372 | 0.110 |
Why?
| | Rhadinovirus | 1 | 2015 | 20 | 0.110 |
Why?
| | Cell Line | 2 | 2018 | 2823 | 0.110 |
Why?
| | RNA, Untranslated | 1 | 2015 | 121 | 0.100 |
Why?
| | Virulence Factors | 1 | 2015 | 174 | 0.100 |
Why?
| | Pandemics | 1 | 2021 | 1707 | 0.090 |
Why?
| | Mice, Inbred C57BL | 2 | 2021 | 5983 | 0.090 |
Why?
| | Proto-Oncogene Proteins c-ets | 1 | 2012 | 56 | 0.090 |
Why?
| | Host-Pathogen Interactions | 1 | 2015 | 361 | 0.090 |
Why?
| | Cell Line, Tumor | 3 | 2015 | 3542 | 0.090 |
Why?
| | Somatomedins | 1 | 2011 | 28 | 0.090 |
Why?
| | RNA-Binding Protein EWS | 1 | 2011 | 31 | 0.080 |
Why?
| | Lung Diseases | 1 | 2018 | 780 | 0.080 |
Why?
| | Biomarkers | 2 | 2022 | 4295 | 0.080 |
Why?
| | Reproducibility of Results | 1 | 2018 | 3413 | 0.080 |
Why?
| | Signal Transduction | 2 | 2012 | 5216 | 0.070 |
Why?
| | Gene Expression Regulation | 1 | 2015 | 2597 | 0.060 |
Why?
| | Humans | 7 | 2026 | 145474 | 0.060 |
Why?
| | Bile Acids and Salts | 1 | 2026 | 163 | 0.050 |
Why?
| | Colorectal Neoplasms | 1 | 2012 | 866 | 0.050 |
Why?
| | Epithelium | 1 | 2022 | 310 | 0.040 |
Why?
| | Glycoproteins | 1 | 2022 | 354 | 0.040 |
Why?
| | Phosphoproteins | 1 | 2022 | 337 | 0.040 |
Why?
| | B-Cell Activating Factor | 1 | 2015 | 21 | 0.030 |
Why?
| | Neutralization Tests | 1 | 2015 | 76 | 0.030 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2015 | 64 | 0.030 |
Why?
| | Disease Models, Animal | 1 | 2026 | 4560 | 0.030 |
Why?
| | Cells, Cultured | 1 | 2022 | 4148 | 0.030 |
Why?
| | Immunoblotting | 1 | 2015 | 295 | 0.030 |
Why?
| | Cell Differentiation | 1 | 2022 | 2046 | 0.030 |
Why?
| | DNA Primers | 1 | 2015 | 505 | 0.030 |
Why?
| | Virulence | 1 | 2015 | 278 | 0.030 |
Why?
| | Gene Deletion | 1 | 2015 | 391 | 0.020 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 977 | 0.020 |
Why?
| | Oncogene Protein p21(ras) | 1 | 2012 | 15 | 0.020 |
Why?
| | Polymerase Chain Reaction | 1 | 2015 | 1041 | 0.020 |
Why?
| | Mice, Inbred BALB C | 1 | 2015 | 1261 | 0.020 |
Why?
| | Epidermal Growth Factor | 1 | 2012 | 162 | 0.020 |
Why?
| | Flow Cytometry | 1 | 2015 | 1162 | 0.020 |
Why?
| | Gene Silencing | 1 | 2011 | 202 | 0.020 |
Why?
| | Fibroblasts | 1 | 2015 | 1025 | 0.020 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2011 | 749 | 0.020 |
Why?
| | Base Sequence | 1 | 2011 | 2170 | 0.020 |
Why?
| | Transcription, Genetic | 1 | 2012 | 1454 | 0.010 |
Why?
| | Male | 1 | 2026 | 72842 | 0.010 |
Why?
| | Female | 1 | 2026 | 78844 | 0.010 |
Why?
|
|
Niemeyer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|